Related references
Note: Only part of the references are listed.HSP25 down-regulation enhanced p53 acetylation by dissociation of SIRT1 from p53 in doxorubicin-induced H9c2 cell apoptosis
Chi Zhang et al.
CELL STRESS & CHAPERONES (2016)
MicroRNA-200a-3p suppresses tumor proliferation and induces apoptosis by targeting SPAG9 in renal cell carcinoma
Xinsheng Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
The Role of SIRT1 in Cancer The Saga Continues
Melissa J. Wilking et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
Tumor suppressive microRNA-200a inhibits renal cell carcinoma development by directly targeting TGFB2
Ruijing Lu et al.
TUMOR BIOLOGY (2015)
The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy
Brock Humphries et al.
ONCOTARGET (2015)
Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer
Lyndsay V. Rhodes et al.
ONCOTARGET (2015)
miR-200a suppresses cell growth and migration by targeting MACC1 and predicts prognosis in hepatocellular carcinoma
Jiye Feng et al.
ONCOLOGY REPORTS (2015)
MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key miRNAs
Haowei He et al.
PLOS ONE (2015)
Tumor suppressive microRNA-1285 regulates novel molecular targets: Aberrant expression and functional significance in renal cell carcinoma
Hideo Hidaka et al.
Oncotarget (2015)
MiR-200a regulates epithelial to mesenchymal transition-related gene expression and determines prognosis in colorectal cancer patients
M. Pichler et al.
BRITISH JOURNAL OF CANCER (2014)
SIRT1 Activation by a c-MYC Oncogenic Network Promotes the Maintenance and Drug Resistance of Human FLT3-ITD Acute Myeloid Leukemia Stem Cells
Ling Li et al.
CELL STEM CELL (2014)
The role of miR-200a in vasculogenic mimicry and its clinical significance in ovarian cancer
Qingmin Sun et al.
GYNECOLOGIC ONCOLOGY (2014)
Significance of PELP1/HDAC2/miR-200 regulatory network in EMT and metastasis of breast cancer
S. S. Roy et al.
ONCOGENE (2014)
High levels of SIRT1 expression enhance tumorigenesis and associate with a poor prognosis of colorectal carcinoma patients
Xiaojing Chen et al.
SCIENTIFIC REPORTS (2014)
Oncogenic micro-RNAs and renal cell carcinoma
Cristina Grange et al.
FRONTIERS IN ONCOLOGY (2014)
SIRT1 promotes thyroid carcinogenesis driven by PTEN deficiency
D. Herranz et al.
ONCOGENE (2013)
The emerging and diverse roles of sirtuins in cancer: a clinical perspective
Hongfeng Yuan et al.
ONCOTARGETS AND THERAPY (2013)
Biochemical relapse following radical prostatectomy and miR-200a levels in prostate cancer
Niall Barron et al.
PROSTATE (2012)
Resveratrol attenuates doxorubicin-induced cardiomyocyte apoptosis in mice through SIRT1-mediated deacetylation of p53
Chi Zhang et al.
CARDIOVASCULAR RESEARCH (2011)
miR-200a-mediated downregulation of ZEB2 and CTNNB1 differentially inhibits nasopharyngeal carcinoma cell growth, migration and invasion
Hongping Xia et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Identifying mRNA targets of microRNA dysregulated in cancer: with application to clear cell Renal Cell Carcinoma
Huiqing Liu et al.
BMC SYSTEMS BIOLOGY (2010)
The role of the miR-200 family in epithelial-mesenchymal transition
Perry S. Mongroo et al.
CANCER BIOLOGY & THERAPY (2010)
Downregulated MicroRNA-200a in Meningiomas Promotes Tumor Growth by Reducing E-Cadherin and Activating the Wnt/β-Catenin Signaling Pathway
Okay Saydam et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Secreted frizzled-related protein 1 loss contributes to tumor phenotype of clear cell renal cell carcinoma
Michelle L. Gumz et al.
CLINICAL CANCER RESEARCH (2007)
Negative control of p53 by Sir2α promotes cell survival under stress
JY Luo et al.
CELL (2001)
hSIR2SIRT1 functions as an NAD-dependent p53 deacetylase
H Vaziri et al.
CELL (2001)
Share Paper
